Opportunity ID: 282340

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-16-024
Funding Opportunity Title: Assessment of Intersubject Variability in Small Airway Delivery with Oral Inhalation Drug Products (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.103 — Food and Drug Administration_Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 18, 2016
Last Updated Date:
Original Closing Date for Applications: May 16, 2016
Current Closing Date for Applications: May 16, 2016
Archive Date: Jun 15, 2016
Estimated Total Program Funding: $200,000
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
City or township governments
For profit organizations other than small businesses
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Independent school districts
Special district governments
Public housing authorities/Indian housing authorities
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Additional Information

Agency Name: Food and Drug Administration
Description: FDA’s CDER is seeking depositional data obtained with a computational modeling approach for small airway delivery to adults with orally inhaled drug products (OIDPs) that are indicated for management of asthma. Possible sources of intersubject variability include lengths and diameters of various airway segments, heterogeneous or homogeneous constriction, and inhalation patterns. An expected outcome is regional deposition data for reference listed drugs that can indicate whether or not the drug product targets small airways in asthmatic patients and the key product attributes that affects the deposition.
Link to Additional Information: Full announcement of RFA-FD-16-024
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Bozoian

Grants Management Specialist

Phone 2404027623
Email:eric.bozoian@fda.hhs.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: Eric Bozoian
Grants Management Specialist
Phone 2404027623
Email: eric.bozoian@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 PKG00221711 Mar 17, 2016 May 16, 2016 View

Package 1

Mandatory forms

282340 RR_SF424_2_0-2.0.pdf

282340 PHS398_CoverPageSupplement_3_0-3.0.pdf

282340 RR_OtherProjectInfo_1_3-1.3.pdf

282340 PerformanceSite_2_0-2.0.pdf

282340 RR_KeyPersonExpanded_2_0-2.0.pdf

282340 RR_Budget_1_3-1.3.pdf

282340 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

282340 RR_SubawardBudget30_1_3-1.3.pdf

282340 PHS_Inclusion_Enrollment_Report-1.0.pdf

282340 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T10:56:08-05:00

Share This Post, Choose Your Platform!

About the Author: